Oonagh Corrigan
Research Subjects
Oonagh Corrigan has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Bryn Williams-Jones
Université de Montréal
3 shared publications Alan Bleakley
Medical Education, Peninsula Medical School, Plymouth, UK
2 shared publications- Alexandros Georgiadis
THIS Institute (The Healthcare Improvement Studies Institute), University of Cambridge, Cambridge, UK
2 shared publications - Charles Weijer
Department of Medicine, Western University, London, Canada
2 shared publications John McMillan
2 shared publications- Julian Archer
School of Medicine and Dentistry, Griffith University, Gold Coast, Australia
2 shared publications
Latest Publications
- 26 July 2018
- Published by Elsevier in Health & Place
- Vol. 53, 71-78
Extraordinary normalcy: Home, relationships and identities in narratives of unpaid care
- 26 July 2018
- Published by Elsevier in Health & Place
- Vol. 53, 71-78
Extraordinary normalcy: Home, relationships and identities in narratives of unpaid care
- Open Access
- 6 July 2017
- Published by Springer Nature in Neuroethics
- Vol. 10 (3) , 389-403
Towards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities
Few empirical studies in the UK have examined the complex social patterns and values behind quantitative estimates of the prevalence of pharmacological cognitive enhancement (PCE). We conducted a qualitative investigation of the social dynamics and moral attitudes that shape PCE practices among university students in two major metropolitan areas in the UK. Our thematic analysis of eight focus groups (n = 66) suggests a moral ecology that operates within the social infrastructure of the university. We find that PCE resilience among UK university students is mediated by normative and cultural judgments disfavoring competitiveness and prescription drug taking. PCE risk can be augmented by social factors such as soft peer pressure and normalization of enhancement within social and institutional networks. We suggest that moral ecological dynamics should be viewed as key mechanisms of PCE risk and resilience in universities. Effective PCE governance within universities should therefore attend to developing further understanding of the moral ecologies of PCE.
- 6 July 2017
- Published by Springer Nature in Neuroethics
- Vol. 10 (3) , 389-403
Open AccessTowards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities
Few empirical studies in the UK have examined the complex social patterns and values behind quantitative estimates of the prevalence of pharmacological cognitive enhancement (PCE). We conducted a qualitative investigation of the social dynamics and moral attitudes that shape PCE practices among university students in two major metropolitan areas in the UK. Our thematic analysis of eight focus groups (n = 66) suggests a moral ecology that operates within the social infrastructure of the university. We find that PCE resilience among UK university students is mediated by normative and cultural judgments disfavoring competitiveness and prescription drug taking. PCE risk can be augmented by social factors such as soft peer pressure and normalization of enhancement within social and institutional networks. We suggest that moral ecological dynamics should be viewed as key mechanisms of PCE risk and resilience in universities. Effective PCE governance within universities should therefore attend to developing further understanding of the moral ecologies of PCE.
- 15 May 2017
- Published by Wiley in Journal of Advanced Nursing
- Vol. 73 (10) , 2318-2326
The diagnosis and lived experience of polycystic ovary syndrome: A qualitative study
Aims: To explore the impact of the diagnosis of polycystic ovary syndrome on health/ill health identity, how women experience this diagnosis and their health beliefs.Background: Polycystic ovary syndrome is a common and heterogeneous condition, giving rise to a wide range of different health concerns. Previous research on polycystic ovary syndrome has been dominated by the medical perspective and less is known about the experiences and needs of women.Design: A qualitative study of 32 premenopausal adult women with polycystic ovary syndrome (diagnosis confirmed by Rotterdam criteria), aged between 18 and 45 years, recruited from a primary and secondary care setting.Methods: Thematic analysis of transcripts from 11 focus groups conducted between 2013‐2015.Results/Findings: Women identified a range of concerns affecting personal and reproductive identity, health knowledge and beliefs: (1) delays and barriers to diagnosis; (2) general lack of empathy by the medical profession; (3) difficulty in accessing specialist referral; (4) lack of information from professionals; (5) inconsistent and sometimes unsatisfactory experiences with medications; (6) insufficient help and advice regarding in/fertility; (7) relative lack of awareness or concern about longer term risks such as diabetes; and (8) significant discrepancies between the beliefs of women with polycystic ovary syndrome and how they experienced the attitudes of healthcare professionals.Conclusions: There appears to be a divergence between women's experience and attitudes of healthcare professionals. The diagnosis, support and lived experience of women with polycystic ovary syndrome could be enhanced by better professional recognition of these concerns, improved knowledge and communication about polycystic ovary syndrome and better access to support and specialist advice.
- 15 May 2017
- Published by Wiley in Journal of Advanced Nursing
- Vol. 73 (10) , 2318-2326
The diagnosis and lived experience of polycystic ovary syndrome: A qualitative study
Aims: To explore the impact of the diagnosis of polycystic ovary syndrome on health/ill health identity, how women experience this diagnosis and their health beliefs.Background: Polycystic ovary syndrome is a common and heterogeneous condition, giving rise to a wide range of different health concerns. Previous research on polycystic ovary syndrome has been dominated by the medical perspective and less is known about the experiences and needs of women.Design: A qualitative study of 32 premenopausal adult women with polycystic ovary syndrome (diagnosis confirmed by Rotterdam criteria), aged between 18 and 45 years, recruited from a primary and secondary care setting.Methods: Thematic analysis of transcripts from 11 focus groups conducted between 2013‐2015.Results/Findings: Women identified a range of concerns affecting personal and reproductive identity, health knowledge and beliefs: (1) delays and barriers to diagnosis; (2) general lack of empathy by the medical profession; (3) difficulty in accessing specialist referral; (4) lack of information from professionals; (5) inconsistent and sometimes unsatisfactory experiences with medications; (6) insufficient help and advice regarding in/fertility; (7) relative lack of awareness or concern about longer term risks such as diabetes; and (8) significant discrepancies between the beliefs of women with polycystic ovary syndrome and how they experienced the attitudes of healthcare professionals.Conclusions: There appears to be a divergence between women's experience and attitudes of healthcare professionals. The diagnosis, support and lived experience of women with polycystic ovary syndrome could be enhanced by better professional recognition of these concerns, improved knowledge and communication about polycystic ovary syndrome and better access to support and specialist advice.
- Open Access
- 1 January 2017
- Published by SAGE Publications in Global Qualitative Nursing Research
- Vol. 4
The Experience of Transitional Care for Non-Medically Complex Older Adults and Their Family Caregivers
Transitional care research has mainly focused on the experiences of older adults with complex medical conditions. To date, few publications examine the experience of transitional care for non-medically complex older adults. In this article, we draw on and thematically analyze interview and audio-diary data collected at three hospitals in Eastern England, and we explore the experience of transitional care of 18 older adults and family caregivers. Participants reported mixed experiences when describing their care transitions, which indicated variations in care quality. To achieve independence and overcome the difficulties with care transitions, participants used a range of interrogative techniques, such as questioning and information seeking. We contend that the existing transitional care interventions are inappropriate to address the care needs of non-medically complex older adults and family caregivers. Implications for frontline health care staff and health services researchers are discussed.
- 1 January 2017
- Published by SAGE Publications in Global Qualitative Nursing Research
- Vol. 4
Open AccessThe Experience of Transitional Care for Non-Medically Complex Older Adults and Their Family Caregivers
Transitional care research has mainly focused on the experiences of older adults with complex medical conditions. To date, few publications examine the experience of transitional care for non-medically complex older adults. In this article, we draw on and thematically analyze interview and audio-diary data collected at three hospitals in Eastern England, and we explore the experience of transitional care of 18 older adults and family caregivers. Participants reported mixed experiences when describing their care transitions, which indicated variations in care quality. To achieve independence and overcome the difficulties with care transitions, participants used a range of interrogative techniques, such as questioning and information seeking. We contend that the existing transitional care interventions are inappropriate to address the care needs of non-medically complex older adults and family caregivers. Implications for frontline health care staff and health services researchers are discussed.
- 20 June 2016
- Published by Taylor & Francis in Ethics & Behavior
- Vol. 27 (4) , 335-350
Frontline Healthcare Staffs’ Experience of Organizing Complex Hospital Discharges: An Ethnographic Study
Existing studies show that nurses often experience moral distress when the care they deliver to patients does not meet their professional values. We draw on ethnographic data collected in June 2015 from one acute care trust in England and present how frontline healthcare staff experience organizing complex hospital discharges. Our findings demonstrate how problems with the panel responsible for allocating funding for National Health Service continuing healthcare cases contributed to healthcare staff experiencing moral distress. Our findings offer a basis for further research on how other aspects of the complex hospital discharge-planning process may contribute to nurses’ experiencing moral distress.
- 20 June 2016
- Published by Taylor & Francis in Ethics & Behavior
- Vol. 27 (4) , 335-350
Frontline Healthcare Staffs’ Experience of Organizing Complex Hospital Discharges: An Ethnographic Study
Existing studies show that nurses often experience moral distress when the care they deliver to patients does not meet their professional values. We draw on ethnographic data collected in June 2015 from one acute care trust in England and present how frontline healthcare staff experience organizing complex hospital discharges. Our findings demonstrate how problems with the panel responsible for allocating funding for National Health Service continuing healthcare cases contributed to healthcare staff experiencing moral distress. Our findings offer a basis for further research on how other aspects of the complex hospital discharge-planning process may contribute to nurses’ experiencing moral distress.
- 1 January 2015
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 90 (1) , 88-93
“No One Has Yet Properly Articulated What We Are Trying to Achieve”
To analyze prevailing definitions of revalidation (i.e., a recently instituted system of ongoing review for all physicians in the United Kingdom), the circumstances of their origin, and proposed applications, after a protracted and sometimes difficult decade in development. This was to support a more consensual approach to revalidation policy before its launch in 2012. In 2010 and 2011, the authors carried out a critical discourse analysis of interviews with 31 medical and legal revalidation policy makers. These individuals represented the main stakeholder bodies, including the General Medical Council, Academy of Medical Royal Colleges, British Medical Association, National Health Service Employers, and the departments of health from across the United Kingdom. The authors identified two overarching discourses: regulation and professionalism, held together by patients as "discursive glue." Regulation frames revalidation as a way to identify "bad apples," requiring a summative approach and minimum standards. Professionalism looks to revalidation as a process by which all doctors improve, requiring evolving standards and a developmental model. These two discourses were not mutually exclusive; indeed, most interviewees used them interchangeably. However, they are in some regards at odds. Their coexistence has been supported by a shared discursive formation around patients. Yet the authors found little patient-centered policy in revalidation in its current form. The authors concluded that patients need to be recognized, making them present with an active voice. They also stressed the importance of established and ongoing evaluation of medical regulation as a policy and process.
- 1 January 2015
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 90 (1) , 88-93
“No One Has Yet Properly Articulated What We Are Trying to Achieve”
To analyze prevailing definitions of revalidation (i.e., a recently instituted system of ongoing review for all physicians in the United Kingdom), the circumstances of their origin, and proposed applications, after a protracted and sometimes difficult decade in development. This was to support a more consensual approach to revalidation policy before its launch in 2012. In 2010 and 2011, the authors carried out a critical discourse analysis of interviews with 31 medical and legal revalidation policy makers. These individuals represented the main stakeholder bodies, including the General Medical Council, Academy of Medical Royal Colleges, British Medical Association, National Health Service Employers, and the departments of health from across the United Kingdom. The authors identified two overarching discourses: regulation and professionalism, held together by patients as "discursive glue." Regulation frames revalidation as a way to identify "bad apples," requiring a summative approach and minimum standards. Professionalism looks to revalidation as a process by which all doctors improve, requiring evolving standards and a developmental model. These two discourses were not mutually exclusive; indeed, most interviewees used them interchangeably. However, they are in some regards at odds. Their coexistence has been supported by a shared discursive formation around patients. Yet the authors found little patient-centered policy in revalidation in its current form. The authors concluded that patients need to be recognized, making them present with an active voice. They also stressed the importance of established and ongoing evaluation of medical regulation as a policy and process.
- Open Access
- 25 September 2013
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 25 (6) , 682-688
Trust in the health-care provider-patient relationship: a systematic mapping review of the evidence base
Trust is important for patients and may be used as an indicator and potential ‘marker’ for how patients evaluate the quality of health care. The review aimed to classify the current evidence base on trust in the patient–provider relationship in order to identify strengths and weaknesses and to point towards areas for future research. Nine electronic databases were searched from 2004 onwards using text and subject heading keywords relating to ‘trust’ and ‘health care’ and ‘relationships’. Abstracts were identified for empirical studies carried out in health-care settings that explicitly examined trust or reported trust-related findings as a secondary outcome. Two review authors assessed the relevance of abstracts and extracted data relating to year published, country of study, clinical speciality, study design and participants. Five hundred and ninety-six abstracts were included. Most reported on patients' trust in providers; were carried out in the USA; collected data in family care or oncology/palliative care settings; used questionnaires and interviews and elicited patients' perspectives. Only one study explicitly set out to examine providers' trust in patients and <5% of included studies reported on providers' trust in patients. Providers' trust in patients remains a neglected area on the trust research agenda. Empirical studies examining the factors that influence providers' trust in patients and how this might affect the quality of care and patient health-related behaviours are urgently needed to readdress this imbalance. Further exploration of this area using observational methods is recommended.
- 25 September 2013
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 25 (6) , 682-688
Open AccessTrust in the health-care provider-patient relationship: a systematic mapping review of the evidence base
Trust is important for patients and may be used as an indicator and potential ‘marker’ for how patients evaluate the quality of health care. The review aimed to classify the current evidence base on trust in the patient–provider relationship in order to identify strengths and weaknesses and to point towards areas for future research. Nine electronic databases were searched from 2004 onwards using text and subject heading keywords relating to ‘trust’ and ‘health care’ and ‘relationships’. Abstracts were identified for empirical studies carried out in health-care settings that explicitly examined trust or reported trust-related findings as a secondary outcome. Two review authors assessed the relevance of abstracts and extracted data relating to year published, country of study, clinical speciality, study design and participants. Five hundred and ninety-six abstracts were included. Most reported on patients' trust in providers; were carried out in the USA; collected data in family care or oncology/palliative care settings; used questionnaires and interviews and elicited patients' perspectives. Only one study explicitly set out to examine providers' trust in patients and <5% of included studies reported on providers' trust in patients. Providers' trust in patients remains a neglected area on the trust research agenda. Empirical studies examining the factors that influence providers' trust in patients and how this might affect the quality of care and patient health-related behaviours are urgently needed to readdress this imbalance. Further exploration of this area using observational methods is recommended.
- 1 September 2011
- Published by Bentham Science Publishers Ltd. in Current Pharmacogenomics and Personalized Medicine
- Vol. 9 (3) , 168-176
Personalized Medicine in a Consumer Age
Abstract: It is now almost twenty years since pharmacogenetics was heralded as the technology most likely to revolutionize medicine by providing personalized medicine to patients and health consumers. While much attention has been focused on the scientific limits and policy failures that have prevented the widespread uptake of personalized medicine to date, this feature article examines the socio-cultural and political aspects of pharmacogenomics and other related technologies such as online genetic testing that aim to deliver personalized medicine. I suggest that science and technology are ‘ co-produced’ with, and shaped by, culture, politics and economics in relation to one another. Drawing on the UK Nuffield Council of Bioethics recently published report, Medical Profiling and Online Medicine: The Ethics of Personalized Healthcare in a Consumer Age, I explore the concept of the ‘consumer’ that has been built into these technologies and argue that despite the push from the commercial sector and the often uncritical acceptance of this by governments, the commercialization of personalized medicine will not succeed unless the benefits are considered as beneficial by those who use it. Such technologies do have the potential to improve healthcare but in order for this to be realized we need a more in-depth understanding of what patients and consumers actually want from such services and we must engage with them as well as doctors and other healthcare professionals. In particular more research is needed to document the experiences of patients and consumers who have utilized services to date, as well as how personalized medicine in its broadest sense is already being delivered by doctors and healthcare practitioners in the clinical context. Finally, a more robust ‘ contextualized’ development of personalized medicine will take considerable effort to achieve if we are to ensure that health inequalities are not further exasperated between the populations of more technologically and economically advanced countries and those living in poor less economically developed ones.
- 1 September 2011
- Published by Bentham Science Publishers Ltd. in Current Pharmacogenomics and Personalized Medicine
- Vol. 9 (3) , 168-176
Personalized Medicine in a Consumer Age
Abstract: It is now almost twenty years since pharmacogenetics was heralded as the technology most likely to revolutionize medicine by providing personalized medicine to patients and health consumers. While much attention has been focused on the scientific limits and policy failures that have prevented the widespread uptake of personalized medicine to date, this feature article examines the socio-cultural and political aspects of pharmacogenomics and other related technologies such as online genetic testing that aim to deliver personalized medicine. I suggest that science and technology are ‘ co-produced’ with, and shaped by, culture, politics and economics in relation to one another. Drawing on the UK Nuffield Council of Bioethics recently published report, Medical Profiling and Online Medicine: The Ethics of Personalized Healthcare in a Consumer Age, I explore the concept of the ‘consumer’ that has been built into these technologies and argue that despite the push from the commercial sector and the often uncritical acceptance of this by governments, the commercialization of personalized medicine will not succeed unless the benefits are considered as beneficial by those who use it. Such technologies do have the potential to improve healthcare but in order for this to be realized we need a more in-depth understanding of what patients and consumers actually want from such services and we must engage with them as well as doctors and other healthcare professionals. In particular more research is needed to document the experiences of patients and consumers who have utilized services to date, as well as how personalized medicine in its broadest sense is already being delivered by doctors and healthcare practitioners in the clinical context. Finally, a more robust ‘ contextualized’ development of personalized medicine will take considerable effort to achieve if we are to ensure that health inequalities are not further exasperated between the populations of more technologically and economically advanced countries and those living in poor less economically developed ones.
- 26 August 2010
- Published by Taylor & Francis in Medical Teacher
- Vol. 32 (9) , 727-732
The changing landscape of medical education in the UK
The UK shares many characteristics with other western developed countries, including a current adherence to the view that defining educational outcomes enables improvements in learning and teaching and a more effective management of the learning and assessment process. There are, however, some features that make UK medical education unique or that give it a distinctive flavour. This article looks at the various forces that shape medical education in the UK and the structures that underpin its delivery, and discusses the distinctive climate that is produced, in which doctors, students and medical teachers are expected to work. We examine and assess these special features of UK medical education and report on the ways in which medical education and medical educators are adapting to the complex and constantly changing environment. We conclude that the healthcare and higher education systems in the UK face unprecedented economic and political challenges over the coming years. Medical educators working within these systems have an important role in ensuring that these challenges are met and that standards are maintained and improved. A stronger professional architecture to support careers in medical education is needed to ensure that those involved in teaching medical students and doctors have the necessary training, time, resources and incentives to do it effectively.
- 26 August 2010
- Published by Taylor & Francis in Medical Teacher
- Vol. 32 (9) , 727-732
The changing landscape of medical education in the UK
The UK shares many characteristics with other western developed countries, including a current adherence to the view that defining educational outcomes enables improvements in learning and teaching and a more effective management of the learning and assessment process. There are, however, some features that make UK medical education unique or that give it a distinctive flavour. This article looks at the various forces that shape medical education in the UK and the structures that underpin its delivery, and discusses the distinctive climate that is produced, in which doctors, students and medical teachers are expected to work. We examine and assess these special features of UK medical education and report on the ways in which medical education and medical educators are adapting to the complex and constantly changing environment. We conclude that the healthcare and higher education systems in the UK face unprecedented economic and political challenges over the coming years. Medical educators working within these systems have an important role in ensuring that these challenges are met and that standards are maintained and improved. A stronger professional architecture to support careers in medical education is needed to ensure that those involved in teaching medical students and doctors have the necessary training, time, resources and incentives to do it effectively.